Aspen Pharmacare Holdings Statistics
Total Valuation
APNHY has a market cap or net worth of 2.85 billion. The enterprise value is 4.37 billion.
| Market Cap | 2.85B |
| Enterprise Value | 4.37B |
Important Dates
The next estimated earnings date is Wednesday, September 3, 2025.
| Earnings Date | Sep 3, 2025 |
| Ex-Dividend Date | Sep 20, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 372.51M |
Valuation Ratios
The trailing PE ratio is 12.00.
| PE Ratio | 12.00 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 4.21 |
| P/FCF Ratio | 19.54 |
| P/OCF Ratio | 9.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of 30.04.
| EV / Earnings | 18.45 |
| EV / Sales | 1.80 |
| EV / EBITDA | 7.45 |
| EV / EBIT | 8.84 |
| EV / FCF | 30.04 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.35 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.22 |
| Debt / FCF | 12.90 |
| Interest Coverage | 4.45 |
Financial Efficiency
Return on equity (ROE) is 5.25% and return on invested capital (ROIC) is 4.79%.
| Return on Equity (ROE) | 5.25% |
| Return on Assets (ROA) | 4.21% |
| Return on Invested Capital (ROIC) | 4.79% |
| Return on Capital Employed (ROCE) | 7.78% |
| Revenue Per Employee | 264,689 |
| Profits Per Employee | 26,036 |
| Employee Count | 9,350 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.89% in the last 52 weeks. The beta is 0.58, so APNHY's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -41.89% |
| 50-Day Moving Average | 8.93 |
| 200-Day Moving Average | 10.22 |
| Relative Strength Index (RSI) | 28.64 |
| Average Volume (20 Days) | 2,077 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APNHY had revenue of 2.41 billion and earned 237.16 million in profits. Earnings per share was 0.53.
| Revenue | 2.41B |
| Gross Profit | 1.09B |
| Operating Income | 491.90M |
| Pretax Income | 317.29M |
| Net Income | 237.16M |
| EBITDA | 571.56M |
| EBIT | 491.90M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
The company has 360.35 million in cash and 1.88 billion in debt, giving a net cash position of -1.52 billion.
| Cash & Cash Equivalents | 360.35M |
| Total Debt | 1.88B |
| Net Cash | -1.52B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.51B |
| Book Value Per Share | 10.15 |
| Working Capital | 1.23B |
Cash Flow
In the last 12 months, operating cash flow was 295.10 million and capital expenditures -149.46 million, giving a free cash flow of 145.64 million.
| Operating Cash Flow | 295.10M |
| Capital Expenditures | -149.46M |
| Free Cash Flow | 145.64M |
| FCF Per Share | n/a |
Margins
Gross margin is 45.16%, with operating and profit margins of 20.40% and 9.84%.
| Gross Margin | 45.16% |
| Operating Margin | 20.40% |
| Pretax Margin | 13.16% |
| Profit Margin | 9.84% |
| EBITDA Margin | 23.71% |
| EBIT Margin | 20.40% |
| FCF Margin | 6.04% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.95%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 1.95% |
| Dividend Growth (YoY) | -1.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 35.75% |
| Buyback Yield | 0.03% |
| Shareholder Yield | 1.98% |
| Earnings Yield | 8.33% |
| FCF Yield | 5.12% |
Stock Splits
The last stock split was on July 18, 2012. It was a forward split with a ratio of 5.
| Last Split Date | Jul 18, 2012 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |